Female non-PAH hPASMCs demonstrated reduced messenger RNA and protein expression of BMPR-II; the signaling intermediary SMAD1; downstream genes; and inhibitors of DNA-binding proteins, ID1 and ID3. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.